A sphingolipid-derived paclitaxel nanovesicle for improved cancer therapy. [PDF]
europepmc +1 more source
Nanoparticles may influence mast cells gene expression profiles without affecting their degranulation function. [PDF]
Newton HS +10 more
europepmc +1 more source
Harnessing albumin's natural tumor-targeting properties: nanoplatform strategies for triple-negative breast cancer therapy. [PDF]
Sheikh M +3 more
europepmc +1 more source
Widespread pustular eruption on paclitaxel infusion. [PDF]
Gard GE +3 more
europepmc +1 more source
Immunomodulatory nanoplatforms with multiple mechanisms of action in cancer treatment. [PDF]
Villa R +8 more
europepmc +1 more source
The rationality guidance index: a framework for reducing redundancy in nanomedicine innovation. [PDF]
Shahiwala A.
europepmc +1 more source
Albumin Nanoparticles for Targeted Cancer Therapy: Mechanistic Insights Into Bio-Inspired Design and Clinical Translation. [PDF]
Anand Raj LFA +3 more
europepmc +1 more source
Advanced Paclitaxel Delivery Systems in Oncology and Cardiovascular Medicine: Current Formulations and Emerging Technologies. [PDF]
Crețeanu A +5 more
europepmc +1 more source
Wolf in Sheep's Clothing: Taming Cancer's Resistance with Human Serum Albumin? [PDF]
Stukan I +6 more
europepmc +1 more source
Protein-Based Nanomaterials for Cancer Therapy: A Comparative and Translational Perspective. [PDF]
Gonzalez-Valdivieso J +7 more
europepmc +1 more source

